診断用心電計の市場規模、シェア、成長分析、製品タイプ別、リードタイプ別、エンドユーザー別、地域別 - 産業予測、2024年～2031年

診断用心電計の世界市場規模は2022年に76億米ドルと評価され、2023年の81億3,000万米ドルから2031年には138億9,000万米ドルに成長し、予測期間（2024-2031年）のCAGRは6.12％で成長する見通しです。

世界の診断用心電計（ECG）市場は、消費者のライフスタイルの変化や虚血性心疾患、高血圧性心疾患、末梢性心疾患などの心血管疾患の有病率の上昇に牽引され、大きな成長が見込まれています。この成長は、世界の高齢者人口の増加に加え、ヘルスケアインフラの進歩や有利な償還政策によってさらに支えられています。加えて、ECG機器における技術革新の進行と遠隔モニタリング・ソリューションの登場が、市場のダイナミクスを高めています。特に、新興国市場は先進国市場よりも成長が加速すると予想され、その背景にはヘルスケア支出の増加と未利用があります。その代表的な例が、Medicalgorithmics社が開発した先進的なECGウェアラブルデバイスであるQpatchが2022年6月に米国食品医薬品局から承認されたことです。特に米国の市場情勢は、進化するヘルスケアシーンにおける高度な診断ソリューションに対する旺盛な需要を反映し、今後の予測期間においても健全なCAGRを維持すると予測されています。こうした動向が続く中、心電計市場は技術の進歩と消費者の健康意識の高まりの両方から恩恵を受け、持続的な成長が期待できます。

目次

イントロダクション

• 調査の目的
• 定義
• 市場範囲

調査手法

• 情報調達
• 二次データソースと一次データソース
• 市場規模予測
• 市場の想定と制限

エグゼクティブサマリー

• 市場概要見通し
• 供給需要動向分析
• セグメント別機会分析

市場力学と見通し

• 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
• ポーターの分析

主な市場の考察

• 主な成功要因
• 競合の程度
• 主な投資機会
• 市場のエコシステム
• 価格分析
• 特許分析
• バリューチェーン分析
• サプライチェーン分析
• 規制情勢
• 貿易分析
• 技術分析
• 顧客と購買基準の分析

診断用心電計市場：製品別

• 市場概要
• デバイス
  • 安静時心電図装置
  • ストレス心電図装置
  • ホルターモニター
  • イベントモニター
  • 埋め込み型ループレコーダー
  • モバイル心臓遠隔測定装置
  • スマート ECGモニター
• ソフトウェアとサービス

診断用心電計市場：リードタイプ別

• 市場概要
• 12リードECGデバイス
• 5リードECGデバイス
• 3リードECGデバイス
• 6リードECGデバイス
• シングルリードECGデバイス
• その他のCGデバイス

診断用心電計市場：エンドユーザー別

• 市場概要
• 病院、診療所、心臓センター
• 外来手術センター
• その他のエンドユーザー

診断用心電計市場：地域別規模

• 市場概要
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ（MEA）
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ地域

競合情勢

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 市場における最近の活動
• 主要企業の市場シェア（2023年）

主要企業プロファイル

• General Electric
• Koninklijke Philips N.V.
• Baxter International Inc.
• Fukuda Denshi
• Mindray Medical International Limited
• Nihon Kohden Corporation
• BPL Medical Technologies
• Schiller Ag
• Bittium
• ACS Diagnostics
• Allengers Medical Systems Ltd.
• Bionet
• Cardiac Insight, Inc.
• BTL
• Meditech Equipment Co. Ltd.
• Midmark Corporation
• AliveCor, Inc.
• Vitalconnect
• Vectracor
• iRhythm Technologies, Inc.
• Borsam Biomedical Instruments Co., Ltd.
• Nasiff Associates, Inc.
• Biomedical Instruments Co. Ltd.
• LifeSignals, Inc.

Global Diagnostic Electrocardiograph Market size was valued at USD 7.60 billion in 2022 and is poised to grow from USD 8.13 billion in 2023 to USD 13.89 billion by 2031, growing at a CAGR of 6.12% during the forecast period (2024-2031).

The global diagnostic electrocardiograph (ECG) market is poised for significant growth, driven by shifting consumer lifestyles and the rising prevalence of cardiovascular diseases such as ischemic heart disease, hypertensive heart disease, and peripheral heart disease. This growth is further supported by advancements in healthcare infrastructure and favorable reimbursement policies, alongside an increasing elderly population worldwide. Additionally, ongoing technological innovations in ECG devices and the emergence of remote monitoring solutions are enhancing market dynamics. Notably, developing regions are expected to experience accelerated growth compared to their developed counterparts, fueled by rising healthcare expenditure and the opportunity to tap into underutilized markets. A prime example is the June 2022 approval by the U.S. Food and Drug Administration of Qpatch, an advanced ECG wearable device created by Medicalgorithmics, which enables precise cardiac arrhythmia diagnosis through real-time ECG signal measurements. In particular, the U.S. diagnostic electrocardiograph market is projected to maintain a healthy compound annual growth rate (CAGR) in the forthcoming forecast period, reflecting a robust demand for advanced diagnostic solutions in the evolving healthcare landscape. As these trends continue to unfold, the ECG market stands to benefit from both technological advancements and increasing health awareness among consumers, positioning it for sustained growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Diagnostic Electrocardiograph market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Diagnostic Electrocardiograph Market Segmental Analysis

Global Diagnostic Electrocardiograph Market is segmented by Product, Lead Type, End User, and Region. Based on Product, the market is segmented into Devices (Resting ECG Devices, Stress ECG Devices, Holter Monitors, Event Monitors, Implantable Loop Recorders, Mobile Cardiac Telemetry Devices, Smart ECG Monitors), Software & Services. Based on Lead Type, the market is segmented into 12-Lead ECG Devices, 5-Lead ECG Devices, 3-Lead ECG Devices, 6-Lead ECG Devices, Single-Lead ECG Devices, Other ECG Lead Devices. Based on End User, the market is segmented into Hospitals, Clinics, And Cardiac Centers, Ambulatory Surgery Centers, Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Diagnostic Electrocardiograph Market

The global diagnostic electrocardiograph (ECG) market is poised for significant growth, propelled by an aging population that is increasingly vulnerable to cardiovascular diseases and heightened consumer awareness regarding non-invasive diagnostic options. The surge in chronic heart disease prevalence, especially in Western nations attributed to unhealthy lifestyles and dietary habits, further underscores the demand for effective cardiac monitoring solutions. With a staggering 850,000 heart attacks occurring annually in the United States alone, including approximately 605,000 first-time incidents, healthcare providers are likely to invest more in ECG technologies to enhance patient care, thereby driving market expansion over the forecast period.

Restraints in the Global Diagnostic Electrocardiograph Market

The global diagnostic electrocardiograph (ECG) market faces significant restraints, primarily due to a lack of awareness about the importance and benefits of ECG in diagnosing cardiovascular diseases. This knowledge gap among healthcare professionals and patients limits the adoption of ECG technology, inhibiting market growth. Additionally, the shortage of skilled technicians and healthcare providers trained in using and interpreting ECG results poses a critical barrier to expanding its usage and improving diagnostic accuracy. These combined factors lead to underutilization of ECG devices, ultimately restraining the market's potential development and hindering access to timely and effective cardiovascular care.

Market Trends of the Global Diagnostic Electrocardiograph Market

The global diagnostic electrocardiograph market is witnessing a significant trend towards the adoption of advanced portable and compact Holter ECG devices, particularly within the home healthcare segment. These innovations offer numerous advantages, including enhanced accessibility and convenience for patients, driving their popularity. Additionally, the surge in collaborations among manufacturers to improve technology and service offerings is further propelling market growth. This confluence of factors is setting a favorable landscape for the Holter ECG market, indicating robust expansion opportunities as healthcare systems adapt to meet the rising demand for remote cardiac monitoring solutions, particularly post-pandemic.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Pricing Analysis
• Patent Analysis
• Value Chain Analysis
• Supply Chain Analysis
• Regulatory Landscape
• Trade Analysis
• Technology Analysis
• Customer & Buying Criteria Analysis

Diagnostic Electrocardiograph Market, By Product

• Market Overview
• Devices
  • Resting ECG Devices
  • Stress ECG Devices
  • Holter Monitors
  • Event Monitors
  • Implantable Loop Recorders
  • Mobile Cardiac Telemetry Devices
  • Smart ECG Monitors
• Software & Services

Diagnostic Electrocardiograph Market, By Lead Type

• Market Overview
• 12-Lead ECG Devices
• 5-Lead ECG Devices
• 3-Lead ECG Devices
• 6-Lead ECG Devices
• Single-Lead ECG Devices
• Other ECG Lead Devices

Diagnostic Electrocardiograph Market, By End User

• Market Overview
• Hospitals, Clinics, And Cardiac Centers
• Ambulatory Surgery Centers
• Other End Users

Diagnostic Electrocardiograph Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• General Electric
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fukuda Denshi
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mindray Medical International Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Kohden Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BPL Medical Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Schiller Ag
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bittium
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ACS Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allengers Medical Systems Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bionet
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardiac Insight, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BTL
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meditech Equipment Co. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Midmark Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AliveCor, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vitalconnect
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vectracor
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• iRhythm Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Borsam Biomedical Instruments Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nasiff Associates, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomedical Instruments Co. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LifeSignals, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments